|
'LIPOSOME
ADVANCES: PROGRESS IN DRUG AND VACCINE DELIVERY' Please print and send to the contact information listed on the form. Register before November 12, 2005 to take advantage of the discounted early registration fees. Corporate Opportunities: Sponsorship, Marketing and Exhibiting The ILS 2005 Corporate Opportunities Package details the sponsorship, marketing, and exhibiting opportunities available in conjunction with the first official ILS Annual Meeting. Please contact Ashka Wirk at the ILS Head Office to explore these opportunities further. Call for Abstracts You are invited to submit one page abstracts for poster presentation at the ILS 2005 Annual Meeting to the Conference Chair, Dr. Gregory Gregoriadis. A number of abstracts will be selected for oral presentation. If sending abstracts by email, please also send a hard copy by regular mail. Deadline for submissions is November 12, 2005 . Program Format • Scientific Symposia • Poster Session • Exhibits • Reception
Program Topics • Liposome technology • Interaction of liposomes with the biological milieu • Long-circulating, targeted and fusogenic liposomes • Liposomes in antimicrobial, cancer, gene and anti-sense therapy, and diagnostic imaging • Liposome-based conventional and genetic vaccines • Liposomes in topical, transdermal and dermal therapy • Preclinical studies and clinical trials • Regulatory issues, patents, licensed products and industrial experience
Speakers and Presentation Titles G. Gregoriadis (UK): Entrapped in liposomes: Breaking the barrier Y. Barenholz (Israel): From nanotechnology to nanomedicine: The liposome experience G. Jensen (USA): Performance and evaluation of conventional liposomes: Lessons from the development of VesCan® A. Janoff (Canada): Capturing synergistic anticancer drug interactions by maintaining fixed drug ratios in vivo J. Backer (USA): Targeting angiogenesis with VEGF-driven liposomes A. Gabizon (Israel): Pros and cons of the liposome platfrom in cancer drug targeting R. Schiffelers (USA): Liposomal corticosteroids in cancer therapy G. Bendas (Germany: Liposomal targeting of tumor vasculature: Options, problems, promises V.P. Torchilin (USA): Liposomes and micelles modified withthe nucleosome-specific monoclonal 2C5 antibody for tumor therapy and imaging G. Cevc (Germany): Ion distribution near lipid bilayer and its role in drug delivery T.M. Allen (Canada): Improving therapeutic outcome for liposomal drugs: Targeting, pharmacokinetics, drug release and bioavailability J. Szebeni (USA): Animal models of liposome-induced and complement-mediated hypersensitivity reactions S.M. Moghimi (UK): The molecular basis of complement activation by PEGylated stealth liposomes I.A.J.M.
Bakker-Woudenberg
(The Netherlands):
Targeted drug delivery to shorten treatment duration
in mycobacterial infections P.R. Cullis (Canada): Immunostimolatory and gene silencing properties of liposomal formulations of oligonucleotides V. Weissig (USA): Liposomes and liposome-like vesicles for drug and DNA delivery to mitochondria G. Storm (The Netherlands):Liposomes for intracellular grug delivery I. Gursel (USA): Immunotherapeutic applications of liposomal CpG ODN J. Wilschut (The Netherlands): Delivery of DNA and siRNA to cells mediated by fusion-active virosomes J. Rejman (Italy): Gene transfer by means of lipo- and polyplexes K.Kostarelos (UK): Engineering nanoparticle-in-liposome therapeutics: From gene therapy to radiotherapy A. Miller (UK): Cationic liposome-mediated DNA versus siRNA delivery: Where are we? M. Keller (UK): Lipidi in vivo delivery of siRNA for therapeutic applications: A challenge of formulation D. Scherman (France): Title to be announced G. Lopez-Berestein (USA): Development of liposomal siRNA for solid tumours D. Hoekstra (The Netherlands): Lipoplex-mediated gene delivery: The first steps L. Leserman (France): Liposome-dendritic cell interactions in vivo: How much do we know? C.R. Alving (USA): Antibodies to liposomal lipids: Effects on HIV B. Frisch (France): Liposome-based systems for anti-tumour vaccination: Influence of lipopeptide adjuvants C. Nicolau (USA): A liposome-based therapeutic vaccine against Alzheimer's disease: Why liposomes? R. Zurbriggen (Switzerland): Immunostimulating reconstituted influenza virosomes: A human approved carrier system for the specific induction of cellular and/or humoural immune response P. Laing (UK): Liposome-based DNA/protein vaccines: The co-delivery approach M. Adamina (Switzerland): Antigen-loaded virosomes in melanoma immuno-therapy Y. Perrie (UK): Liposomal TB vaccines: Can we improve on BCG? H. Bueno da Costa (Brasil): Enhanced liposomal vaccine formulation and performance: Simple physicochemical and immunological approaches A. Wagner (Austria): GMP-production of liposomal vaccines and therapeutics A.T. Florence (UK): Further studies on tethers, coralled microparticles and manipulated vesicles A. Fahr (Germany): Transfer of lipophilic drugs between liopsomal membranes and biological interfaces: Consequences for drug delivery M. Brandl (Norway): Vesicular phospholipid gels I.F. Uchegbu (UK): Nanoparticle engineering for pharmaceuticals C. Ladaviere (France): Physicochemical and interfacial investigation of lipid/polymer particle assemblies J. Bouwstra (The Netherlands): Elastic vesicles as a tool for dermal and transdermal delivery P. Frederik (The Netherlands): Liposome dynamics resolved by cryo-electron micoscopy probing into drug and gene targeting B. Papahadjopoulos- Sternberg (USA): Seeing mono- and bilayer-stabilized nanostructures suitable for drug and gene delivery O. Rozenberg (Russia): Liposomal forms of lung surfactant: Surfactant therapy of acute and chronic lung diseases All hotels shown below are within walking distance of the School of Pharmacy, University of London. Please reserve rooms directly with the hotels. Holiday Inn Bloomsbury Hotel Tel: ++44 08704 009 222 Fax: ++44 (0)20 7713 5954 Rates: £99 rates for single; £99 for double; Prices include breakfast To reserve a room at the rates shown, please mention to the operator that you are participating in a conference at the University of London. If necessary, please ask them to contact Professor Gregoriadis. Imperial London Hotels Ltd. Tel: ++44 (0)20 7278 7871 Fax: ++44 (0)20 7837 4653 E-mail: info@imperialhotels.co.uk Rates: £40 to £73 for single; £52 to £98 for double; Prices include breakfast Crescent Hotel Tel: ++44 (0)20 7387 1515 Fax: ++44 (0) 20 7383 2054 Rates: £44 to £71 for single; £84 for double; Prices include breakfast
|
